- Home
- CMCM vs STRO Comparison
CMCM vs STRO Comparison
Compare CMCM & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCM
- STRO
- Stock Information
- Founded
- CMCM 2009
- STRO 2003
- Country
- CMCM China
- STRO United States
- Employees
- CMCM N/A
- STRO N/A
- Industry
- CMCM Computer Software: Prepackaged Software
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMCM Technology
- STRO Health Care
- Exchange
- CMCM Nasdaq
- STRO Nasdaq
- Market Cap
- CMCM 148.5M
- STRO 147.6M
- IPO Year
- CMCM 2014
- STRO 2018
- Fundamental
- Price
- CMCM $4.38
- STRO $0.74
- Analyst Decision
- CMCM
- STRO Buy
- Analyst Count
- CMCM 0
- STRO 7
- Target Price
- CMCM N/A
- STRO $6.83
- AVG Volume (30 Days)
- CMCM 36.9K
- STRO 2.2M
- Earning Date
- CMCM 03-26-2025
- STRO 03-13-2025
- Dividend Yield
- CMCM N/A
- STRO N/A
- EPS Growth
- CMCM N/A
- STRO N/A
- EPS
- CMCM N/A
- STRO N/A
- Revenue
- CMCM $110,544,725.00
- STRO $62,043,000.00
- Revenue This Year
- CMCM $37.71
- STRO N/A
- Revenue Next Year
- CMCM $39.26
- STRO N/A
- P/E Ratio
- CMCM N/A
- STRO N/A
- Revenue Growth
- CMCM 20.52
- STRO N/A
- 52 Week Low
- CMCM $2.70
- STRO $0.72
- 52 Week High
- CMCM $6.78
- STRO $5.88
- Technical
- Relative Strength Index (RSI)
- CMCM 33.91
- STRO 26.77
- Support Level
- CMCM $4.90
- STRO $0.72
- Resistance Level
- CMCM $5.07
- STRO $0.80
- Average True Range (ATR)
- CMCM 0.27
- STRO 0.10
- MACD
- CMCM -0.05
- STRO -0.01
- Stochastic Oscillator
- CMCM 8.41
- STRO 5.68
About CMCM Cheetah Mobile Inc. each representing fifty (50)
Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.